Turning a toxoplasma protein into a tool against infection

May 10, 2017, University of Malaya
Toxoplasmosis is a parasitic disease that most severely affects people with a weakened immune system. Caused by the parasite Toxoplasma gondii, it spreads due to consumption of undercooked meat and exposure to cat faeces. Credit: Kateryna Kon / 123rf

Toxoplasmosis is a parasitic disease that most severely affects people with a weakened immune system. Caused by the parasite Toxoplasma gondii, it spreads due to consumption of undercooked meat and exposure to cat faeces. Although it can be mild, causing only flu-like symptoms, it can lead to brain problems such as lesions and encephalitis, in addition to other neurological disorders. It is not generally spread between humans, but can be passed to an unborn child if a pregnant woman is infected.

Current treatment options for toxoplasmosis are limited. Yee-Ling Lau and colleagues at the University of Malaya wanted to investigate potential vaccine candidates to prevent infection.

T. gondii invades cells with the help of a protein, ROP1, which is secreted within the parasite. The team looked at whether exposure to this protein could protect mice that were later infected with T. gondii. Past studies have shown that ROP1 does create some in cell cultures and in animals, but until now, no one has gone on to infect vaccinated mice with live parasites to test the effectiveness of the immune response.

Lau and colleagues took groups of mice and gave them three vaccinations at twoweek intervals. Some received a ROP1 treatment intramuscularly or under the skin, while others received a placebo using the same two injection techniques. Each group of mice was later given lethal doses of a virulent T. gondii strain.

The mice that had received the ROP1 treatment survived longer than the controls, regardless of the method of vaccination. The vaccinated mice survived up to 16 days, whereas the controls all succumbed to T. gondii infection after just nine. The researchers caution, however, that none of the vaccinated had complete protection.

The team believes that the protection occurs through cell-mediated immune responses; meaning that the immunity is not generated by antibodies, but by the activation of molecules in the cell. Although this work is promising, further work needs to be done to investigate other agents that could be combined with ROP1 to achieve better results, or even complete protection against the .

Explore further: How a nasty, brain-eating parasite could help us fight cancer

Related Stories

How a nasty, brain-eating parasite could help us fight cancer

August 26, 2016
We've known since the turn of the 20th century that some infectious diseases are a major risk for developing specific cancers. More worryingly, about one-sixth of cancers worldwide are attributable to infectious agents. Globally, ...

Parasite proteins prompt immune system to fight off ovarian tumors in mice

July 22, 2016
Scientists identified the specific proteins secreted by the parasite Toxoplasma gondii that cause the immune system in mice to attack established ovarian tumors. The study, led by David Bzik of the Geisel School of Medicine ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016
Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

New study brings long-sought vaccines for deadly parasite closer to reality

December 13, 2012
One major cause of illness from food-borne diseases is the parasite Toxoplasma gondii (T. gondii). New insights into how the immune system combats T. gondii are provided in a study published by Cell Press December 13th in ...

Scientists find Huntington's disease mice respond differently to common infection

September 19, 2016
Casual conversation three years ago between University of Wyoming veterinary sciences and molecular biology researchers resulted in findings that show for the first time mice engineered to have the human genetic disorder ...

Recommended for you

Nanoparticle vaccine offers universal protection against influenza A viruses, study finds

January 24, 2018
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia ...

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.